Scleroderma: Difference between revisions

Jump to navigation Jump to search
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{DiseaseDisorder infobox |
  Name          = Systemic sclerosis |
  ICD10          = {{ICD10|M|34||m|30}} |
  ICD9          = {{ICD9|710.1}} |
  ICDO          = |
  Image          = Scleroderma-301.jpg|
  Caption        = MCP, PIP and DIP joints destructions in patient with Scleroderma. <br> [http://www.radswiki.net Image courtesy of RadsWiki]|
  OMIM          = 181750 |
  MedlinePlus    = 000429 |
  DiseasesDB    = 12845 |
  MeshID        = D012595 |
}}
{{Scleroderma}}
{{Scleroderma}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}


'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''


{{SK}} Systemic sclerosis
{{SK}} Systemic sclerosis; CREST syndrome; limited scleroderma; progressive systemic sclerosis; localized scleroderma; mixed connective disease; morphea - linear; sclerosis, systemic; systemic scleroderma


===Click [[The Heart in Progressive Systemic Sclerosis (Scleroderma)|here]] for The Heart in Scleroderma===
===Click [[The Heart in Progressive Systemic Sclerosis (Scleroderma)|here]] for The Heart in Scleroderma===


==[[Scleroderma overview|Overview]]==
==[[Scleroderma overview|Overview]]==
Line 33: Line 19:
==[[Scleroderma causes|Causes]]==
==[[Scleroderma causes|Causes]]==


==[[Scleroderma differential diagnosis|Differentiating Scleroderma from other Diseases]]==
==[[Differentiating Scleroderma from other diseases|Differentiating Scleroderma from other Diseases]]==


==[[Scleroderma epidemiology and demographics|Epidemiology and Demographics]]==
==[[Scleroderma epidemiology and demographics|Epidemiology and Demographics]]==


==[[Scleroderma risk factors|Risk Factors]]==
==[[Scleroderma risk factors|Risk Factors]]==
==[[Scleroderma screening|Screening]]==


==[[Scleroderma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==[[Scleroderma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==


==Diagnosis==
==Diagnosis==
[[Scleroderma history and symptoms|History and Symptoms]] | [[Scleroderma physical examination|Physical Examination]] | [[Scleroderma laboratory findings|Laboratory Findings]] | [[Scleroderma CT|CT]] | [[Scleroderma MRI|MRI]] | [[Scleroderma echocardiography or ultrasound|Ultrasound]] | [[Scleroderma other imaging findings|Other Imaging Findings]] | [[Scleroderma other diagnostic studies|Other Diagnostic Studies]]
[[Scleroderma diagnostic study of choice|Diagnostic Study of Choice]] | [[Scleroderma history and symptoms|History and Symptoms]] | [[Scleroderma physical examination|Physical Examination]] | [[Scleroderma laboratory findings|Laboratory Findings]] | [[Scleroderma electrocardiogram|Electrocardiogram]] | [[Scleroderma x ray|X Ray]] | [[Scleroderma CT|CT]] | [[Scleroderma MRI|MRI]] | [[Scleroderma echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Scleroderma other imaging findings|Other Imaging Findings]] | [[Scleroderma other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Scleroderma medical therapy|Medical Therapy]] | [[Scleroderma surgery|Surgery]] | [[Scleroderma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Scleroderma future or investigational therapies|Future or Investigational Therapies]]
[[Scleroderma medical therapy|Medical Therapy]] | [[Scleroderma surgery|Surgery]] | [[Scleroderma primary prevention|Primary Prevention]] | [[Scleroderma secondary prevention|Secondary Prevention]] | [[Scleroderma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Scleroderma future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==

Revision as of 16:29, 26 March 2018

Scleroderma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Scleroderma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Scleroderma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Scleroderma

CDC on Scleroderma

Scleroderma in the news

Blogs on Scleroderma

Directions to Hospitals Treating Scleroderma

Risk calculators and risk factors for Scleroderma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

For patient information click here

Synonyms and keywords: Systemic sclerosis; CREST syndrome; limited scleroderma; progressive systemic sclerosis; localized scleroderma; mixed connective disease; morphea - linear; sclerosis, systemic; systemic scleroderma

Click here for The Heart in Scleroderma

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Scleroderma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:Diseases of the musculoskeletal system and connective tissue

de:Sklerodermie it:Sclerodermia he:סקלרודרמה nl:Sclerodermie sk:Sklerodermia sv:Sklerodermi


Template:WikiDoc Sources